Abstract
We present the clinical and genomic epidemiological perspective of the first case of Artesunate treatment failure in an Omani citizen admitted to a hospital in Muscat who originally contracted
Plasmodium falciparum
malaria during travel to Dar Es Salaam, Tanzania.